Creyon
is a California-based preclinical stage company that researches and commercializes oligonucleotide medicines for the treatment of respiratory diseases... Read moreCreyon
is a California-based preclinical stage company that researches and commercializes oligonucleotide medicines for the treatment of respiratory diseases... Read more
2019
PrivateIndependent Company
News
Sep 10, 2024
Outsourcing-Pharma
Creyon: Creyon Bio secures second patent for AI-powered oligonucleotide engineering
May 15, 2024
Yahoo
Creyon: Creyon Bio Using AI to Treat Rare Neurological Diseases
May 07, 2024
GlobalNewswire
Press Release: Creyon : Creyon Bio to Present Clinical Data on Rapid AI-Enabled Engineering of Oligonucleotide-Based Medicines at the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting
May 03, 2024
Pharmabiz
Creyon: Creyon Bio, Cajal Neuroscience partner to develop oligonucleotidebased medicines for neurodegenerative diseases
Jul 21, 2023
Citybizlist
Creyon: Creyon Bio Appoints COO Jason Ferrone, JD, And CFO Robert Muir
May 17, 2022
FirstWord Pharma
Creyon: Creyon Bio Announces David Fajgenbaum as Company Advisor and Board Observer
Mar 13, 2022
MedCity News
Creyon: Creyon Bio gets some green for a new take on AI and genetic meds R&D
Mar 09, 2022
socalTECH
Creyon: Creyon Bio Gets $40M For Precision Medicine
Mar 08, 2022
FierceBiotech
Creyon: Creyon joins wave of AI biotechs with $40M to create 'on demand' RNA-based medicines
